Extracorporeal membrane oxygenation (ECMO) in patients with tuberculosis: systematic review and meta-analysis of 43 cases.

"Declarations Ethics approval and consent to participateAs this was a literature review and meta-analysis no ethical approval or consent to participate was required. Consent for publicationNot applicable. Competing interestsRaja Idris received speaker fees from Tillotts Pharma GmbH.Ann-Sophie Zielbauer received speaker fees from Tillotts Pharma GmbH.Julia Koepsell received speaker fees from Tillotts Pharma GmbH.Jan Kloka has nothing to declare.Nils Wetzstein has nothing to declare. Competing interests Raja Idris received speaker fees from Tillotts Pharma GmbH. Ann-Sophie Zielbauer received speaker fees from Tillotts Pharma GmbH. Julia Koepsell received speaker fees from Tillotts Pharma GmbH. Jan Kloka has nothing to declare. Nils Wetzstein has nothing to declare."

"Funding Open Access funding enabled and organized by Projekt DEAL. This is an investigator-initiated study that did not receive any specific funding. No external source of funding was used for this project."

"This systematic review was performed in accordance with the current Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement and checklist (PRISMA) []. A prespecified protocol for this systematic review was registered with the International Prospective Register of Systematic Reviews (PROSPERO CRD42022357405) on September 23rd 2022. We conducted a systematic review to identify studies about ECMO usage in the management of tuberculosis patients to investigate the efficacy of ECMO therapy within this cohort."